why is semaglutide being discontinued FDA ends shortage, closing the door on compounded Wegovy, Ozempic semaglutide discontinued Should Ozempic (semaglutide)

3 Works cited FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize, accessed February 2, 2026, Semaglutide Shortage Resolved McDermott Will & Schulte, accessed February 2, 2026, GLP-1 Update: Court Backs FDA in Tirzepatide Compounding Case, accessed February 2, 2026, The Return of 503B Compounding of GLP-1 Medications Frier Levitt, accessed February 2, 2026, The Strategic Imperative of Pharmaceutical Competitor Analysis: A Comprehensive Guide for 2026 and Beyond DrugPatentWatch, accessed February 2, 2026, Maximizing ROI on Drug Development by Monitoring Competitive Patent Portfolios, accessed February 2, 2026, Compounded Drug Products That Are Essentially Copies of Approved Drug Products Under Section 503B of the Federal Food, Drug, and Cosmetic Act FDA, accessed February 2, 2026, GLP-1 Weight-Loss Drugs Off Shortage List

They should understand that standard titration may not apply and that more frequent monitoring is needed

First, weight loss drugs should always be paired with lifestyle improvements better diet, exercise, and protein intake

No FDA-approved protocols exist

Weight loss and the use of GLP-1RAs are contraindications in individuals with atypical anorexia nervosa, even for those with a BMI in the overweight or obese range